Evidence map›Paper›PMID 9691100›Full record

ArticleThe Journal of clinical investigation1998

Mobilization of potent plasma bactericidal activity during systemic bacterial challenge. Role of group IIA phospholipase A2.

Y Weinrauch, C Abad, N S Liang, S F Lowry, J Weiss

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of clinical investigation, 1998. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 48 papers.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed
7.3field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

48 citing papers in PubMed, 148 citations in OpenAlex.

  1. Review
  2. Secreted Phospholipases A2: Drivers of Inflammation and Cancer.International journal of molecular sciences · 2024
    Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Regulatory Roles of Phospholipase AFrontiers in immunology · 2022
    Review
  8. Human Group IIA Phospholipase AMolecules (Basel, Switzerland) · 2021
    Review
  9. Updating Phospholipase ABiomolecules · 2020
    Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Epithelial-Cell-Derived Phospholipase ACell host & microbe · 2017
    Article
  19. Lipoquality control by phospholipase AProceedings of the Japan Academy. Series B, Physical and biological sciences · 2017
    Review
  20. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Y WeinrauchDepartment of Microbiology, New York University School of Medicine, New York 10016, USA. weissj01@mcrcr.med.nyu.edu
C Abad
N S Liang
S F Lowry
J Weiss
New York University · USCornell University · US

Funding

NEUTROPHILS AND BACTERIAL PHOSPHOLIPID DEGRADATIONR01AI018571 · NIAID · UNIVERSITY OF IOWA · PI WEISS, JERROLD P · 1985 to 2002
$1.0M
MICROBICIDAL ACTIVITY OF LEUKOCYTES: MEMBRANE FACTORSR01DK005472 · NIDDK · UNIVERSITY OF IOWA · PI WEISS, JERROLD P · 1986 to 2002
$958k
MICROBICIDAL ACTIVITY OF LEUKOCYTES: ACTIVE FACTORSR37DK005472 · NIDDK · NEW YORK UNIVERSITY · PI ELSBACH, PETER · 1987 to 1994
–
NIAID NIH HHS AI 18571NIDDK NIH HHS DK 05472
6 · The paper itself

Abstract

Extracellular mobilization of Group IIA 14-kD phospholipase A2 (PLA2) in glycogen-induced rabbit inflammatory peritoneal exudates is responsible for the potent bactericidal activity of the inflammatory fluid toward Staphylococcus aureus (1996. J. Clin. Invest. 97:250-257). Because similar levels of PLA2 are induced in plasma during systemic inflammation, we have tested whether this gives rise to plasma bactericidal activity not present in resting animals. Baboons were injected intravenously (i.v.) with a lethal dose of Escherichia coli and plasma or serum was collected before and at hourly intervals after injection. After infusion of bacteria, PLA2 levels in plasma and serum rose > 100-fold over 24 h to approximately 1 microg PLA2/ml. Serum collected at 24 h possessed potent bactericidal activity toward S. aureus, Streptococcus pyogenes, and encapsulated E. coli not exhibited by serum collected from unchallenged animals. Bactericidal activity toward S. aureus and S. pyogenes was nearly completely blocked by a monoclonal antibody to human Group IIA PLA2 and addition of purified human Group IIA PLA2 to prechallenge serum conferred potent antistaphylococcal and antistreptococcal activity equal to that of the 24 h post-challenge serum. PLA2-dependent bactericidal activity was enhanced approximately 10x by factor(s) present constitutively in serum or plasma. Bactericidal activity toward encapsulated E. coli was accompanied by extensive bacterial phospholipid degradation mediated, at least in part, by the mobilized Group IIA PLA2 but depended on the action of other bactericidal factors in the 24-h serum. These findings further demonstrate the contribution of Group IIA PLA2 to the antibacterial potency of biological fluids and suggest that mobilization of this enzyme during inflammation may play an important role in host defense against invading bacteria.

Indexed as

Blood Bactericidal ActivityAnimalsBacteremiaEscherichia coli InfectionsGroup II Phospholipases A2HumansPapioPhosphodiesterase InhibitorsPhospholipases APhospholipases A2PhospholipidsRecombinant Fusion ProteinsStaphylococcal InfectionsStreptococcal InfectionsGroup II Phospholipases A2Phosphodiesterase InhibitorsPhospholipases APhospholipases A2PhospholipidsRecombinant Fusion Proteins

Identifiers

PMID9691100
PMCPMC508924
OpenAlexW2048134681

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.